Thursday, November 13, 2025
Home > COVID

Novavax (NVAX) Stock Up 8% as FDA Approves Updated Covid Vaccine

The updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential to evade immunity conferred by earlier versions of the vaccine.  In a recent development, stocks of Novavax Inc (NASDAQ: NVAX) jumped 8.2% yesterday following the Food and Drug Administration’s (FDA) approval

Read More

Merck Q1 2023 Report Shows Revenue Drop as COVID Treatment Sales Crash, MRK Stock Down 1%

Affected by reduced demand for Covid drug Molnupiravir, Merck has published reduced revenue figures according to its Q1 2023 report. Multinational pharmaceutical giant Merck & Co Inc (NYSE: MRK) has released its Q1 2023 report. The company’s figures show a reduction in revenue due to several factors, including a plunge in

Read More

European Commission Backed Blockchain Organisaton INATBA Joins WEF COVID Action Platform to Address Global Challenges

The Brussels-based International Association for Trusted Blockchain Applications (INATBA) has joined the World Economic Forum’s COVID Action Platform which brings together the World Health Organization (WHO), corporate CEOs and top experts from leading global organisations to coordinate multi-stakeholder contributions into the fight to combat the global spread of coronavirus.According to

Read More